Source: BioSpace

Rafarma Pharmaceuticals: Rafarma to be Acquired by R. & D. Biocogency Laboratories Inc.

Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce that it has reached an agreement to be acquired by R. & D. Biocogency Laboratories Inc. Ltd ("Biocogency"). Under the agreed terms, Bio-cogency will acquire majority control of Rafarma Pharmaceuticals Inc. upon completion of Biocogency's transition to GAAP reporting standards and finalization of acquisition agreements. For Biocogency, this acquisition will be an oppor

Read full article »
Est. Annual Revenue
$5.0-25M
Agree?
Est. Employees
1-25
Agree?
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100